These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 33334279)

  • 1. Exosomes: Critical Mediators of Tumour Microenvironment Reprogramming.
    Malla RR; Shailender G; Kamal MA
    Curr Med Chem; 2021; 28(39):8182-8202. PubMed ID: 33334279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
    Sundararajan V; Sarkar FH; Ramasamy TS
    Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.
    Yang E; Wang X; Gong Z; Yu M; Wu H; Zhang D
    Signal Transduct Target Ther; 2020 Oct; 5(1):242. PubMed ID: 33077737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
    Jena BC; Mandal M
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes: Key mediators of metastasis and pre-metastatic niche formation.
    Lobb RJ; Lima LG; Möller A
    Semin Cell Dev Biol; 2017 Jul; 67():3-10. PubMed ID: 28077297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
    Cheng YQ; Wang SB; Liu JH; Jin L; Liu Y; Li CY; Su YR; Liu YR; Sang X; Wan Q; Liu C; Yang L; Wang ZC
    Cell Prolif; 2020 Aug; 53(8):e12865. PubMed ID: 32588948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein cargo in extracellular vesicles as the key mediator in the progression of cancer.
    Hánělová K; Raudenská M; Masařík M; Balvan J
    Cell Commun Signal; 2024 Jan; 22(1):25. PubMed ID: 38200509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
    Wu Q; Zhou L; Lv D; Zhu X; Tang H
    J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Engaged Role of Tumor Microenvironment in Cancer Metabolism: Focusing on Cancer-Associated Fibroblast and Exosome Mediators.
    Ilkhani K; Bastami M; Delgir S; Safi A; Talebian S; Alivand MR
    Anticancer Agents Med Chem; 2021; 21(2):254-266. PubMed ID: 32914721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
    Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
    Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Glypican-1 in the Tumour Microenvironment.
    Lund ME; Campbell DH; Walsh BJ
    Adv Exp Med Biol; 2020; 1245():163-176. PubMed ID: 32266658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment.
    Whiteside TL
    Semin Immunol; 2018 Feb; 35():69-79. PubMed ID: 29289420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haematopoietic cell-derived exosomes in cancer development and therapeutics: From basic science to clinical practice.
    Lin WC; Lin YT; Chao HC; Lin YY; Hwang WL
    Clin Transl Med; 2023 Oct; 13(10):e1448. PubMed ID: 37830387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distinct roles of exosomes in tumor-stroma crosstalk within gastric tumor microenvironment.
    Zhang H; Yang M; Wu X; Li Q; Li X; Zhao Y; Du F; Chen Y; Wu Z; Xiao Z; Shen J; Wen Q; Hu W; Cho CH; Chen M; Zhou Y; Li M
    Pharmacol Res; 2021 Sep; 171():105785. PubMed ID: 34311072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multifaceted involvement of exosomes in tumor progression: Induction and inhibition.
    Gu WJ; Shen YW; Zhang LJ; Zhang H; Nagle DG; Luan X; Liu SH
    MedComm (2020); 2021 Sep; 2(3):297-314. PubMed ID: 34766148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome in tumour microenvironment: overview of the crosstalk between normal and cancer cells.
    Roma-Rodrigues C; Fernandes AR; Baptista PV
    Biomed Res Int; 2014; 2014():179486. PubMed ID: 24963475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression.
    Ye L; Li Y; Zhang S; Wang J; Lei B
    Cytokine Growth Factor Rev; 2023 Oct; 73():27-39. PubMed ID: 37291031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour microenvironment: a non-negligible driver for epithelial-mesenchymal transition in colorectal cancer.
    Han L; Wang S; Wei C; Fang Y; Huang S; Yin T; Xiong B; Yang C
    Expert Rev Mol Med; 2021 Nov; 23():e16. PubMed ID: 34758892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rising roles of exosomes in the tumor microenvironment reprogramming and cancer immunotherapy.
    Wu Y; Han W; Dong H; Liu X; Su X
    MedComm (2020); 2024 Apr; 5(4):e541. PubMed ID: 38585234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes are the Driving Force in Preparing the Soil for the Metastatic Seeds: Lessons from the Prostate Cancer.
    Saber SH; Ali HEA; Gaballa R; Gaballah M; Ali HI; Zerfaoui M; Abd Elmageed ZY
    Cells; 2020 Feb; 9(3):. PubMed ID: 32121073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.